Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GB GROUP PLC Share Issue/Capital Change 2019

Dec 9, 2019

7662_rns_2019-12-09_f811c3cd-d6ed-4e8e-9658-4b845ed0b80e.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1230W

GB Group PLC

09 December 2019

9 December 2019

GB GROUP PLC

("GBG" or the "Company")

Admission of securities to trading

GBG announces that it has issued 7,352 ordinary shares of 2.5p each ("Ordinary Shares") as deferred and final consideration in relation to an acquisition of assets made in 2017.

Application has been made for the 7,352 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will take place on or around 11 December 2019.

Following Admission, the Ordinary Shares being issued will rank pari passu with the existing Ordinary Shares. The total number of Ordinary Shares in issue will be 194,141,090 and the total number of voting rights will also be 194,141,090. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

- Ends-

For further information, please contact:

GB Group plc

John Constantin, Company Secretary
01244 657333
Peel Hunt LLP (Nominated Adviser and Broker)

Edward Knight

Edward Allsopp

Nick Prowting
020 7418 8900
Website www.gbgplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEBIBDDIXGBGCI